EMPAGLIFLOZINA 25 MG COM REV CT BL AL PLAS PVC/PVDC OPC X 30
Presentation · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brazil
-
Registration number
1058310240041 -
GGREM
526126070189507 -
Barcode
7896004823485
What the source publishes
- Holder
- GERMED FARMACEUTICA LTDA
- Active ingredients
- EMPAGLIFLOZINA
- Package
- 25 MG COM REV CT BL AL PLAS PVC/PVDC OPC X 30
- Supply regime
- Tarja Vermelha
- Product type
- Genérico
- Therapeutic class
- A10P1 - ANTIDIABÉTICOS INIBIDORES DE SGLT2, PUROS
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "EMPAGLIFLOZINA 25 MG COM REV CT BL AL PLAS PVC/PVDC OPC X 30",
"holder": "GERMED FARMACEUTICA LTDA",
"stripe": "Tarja Vermelha",
"barcodes": [
"7896004823485"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "526126070189507",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "45.992.062/0001-65",
"priceRegime": "Regulado",
"productName": "EMPAGLIFLOZINA",
"productType": "Genérico",
"hospitalOnly": false,
"presentation": "25 MG COM REV CT BL AL PLAS PVC/PVDC OPC X 30",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha",
"factoryPrices": {
"icms-0": "129.12",
"icms-12": "146.73",
"icms-17": "155.57",
"icms-18": "157.46",
"icms-19": "159.41",
"icms-20": "161.40",
"icms-21": "163.44",
"icms-22": "165.54",
"icms-23": "167.69",
"icms-17.5": "156.51",
"icms-19.5": "160.40",
"icms-20.5": "162.42",
"icms-22.5": "166.61",
"icms-12-alc": "131.01",
"icms-17-alc": "138.90",
"icms-18-alc": "140.59",
"icms-19-alc": "142.33",
"icms-20-alc": "144.11",
"icms-21-alc": "145.93",
"icms-22-alc": "147.80",
"icms-23-alc": "149.72",
"withoutTaxes": "115.29",
"icms-17.5-alc": "139.74",
"icms-19.5-alc": "143.21",
"icms-20.5-alc": "145.01",
"icms-22.5-alc": "148.76"
},
"pisCofinsList": "Negativa",
"substanceText": "EMPAGLIFLOZINA",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "173.21",
"icms-12": "196.83",
"icms-17": "208.69",
"icms-18": "211.23",
"icms-19": "213.84",
"icms-20": "216.51",
"icms-21": "219.25",
"icms-22": "222.07",
"icms-23": "224.95",
"icms-17.5": "209.95",
"icms-19.5": "215.17",
"icms-20.5": "217.88",
"icms-22.5": "223.50",
"icms-12-alc": "181.11",
"icms-17-alc": "192.02",
"icms-18-alc": "194.36",
"icms-19-alc": "196.76",
"icms-20-alc": "199.22",
"icms-21-alc": "201.74",
"icms-22-alc": "204.32",
"icms-23-alc": "206.98",
"withoutTaxes": "159.38",
"icms-17.5-alc": "193.18",
"icms-19.5-alc": "197.98",
"icms-20.5-alc": "200.47",
"icms-22.5-alc": "205.65"
},
"invalidBarcodes": [],
"activeSubstances": [
"EMPAGLIFLOZINA"
],
"therapeuticClass": "A10P1 - ANTIDIABÉTICOS INIBIDORES DE SGLT2, PUROS",
"commercialisation": {
"year": 2025,
"marketed": false
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1058310240041",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "A10P1",
"commercialDestination": null,
"registrationNumberFlag": null
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:526126070189507"